-
Biopharma ramps up lobbying spend as drug pricing legislation nears — Roche culls two COVID-19 hopefuls amid Q1 clear-out — FDA offers scathing review of Emergent plantSee more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Culture
Discussion in 'Dermira' started by anonymous, Mar 10, 2020 at 5:56 PM.
Tags:
Add Tags